Literature DB >> 22536508

Very Low Frequency of PAD in People with CHD in Six Middle Eastern Countries.

Hasan Kutsi Kabul1, Ilker Tasci.   

Abstract

Entities:  

Year:  2012        PMID: 22536508      PMCID: PMC3321307          DOI: 10.1155/2012/409057

Source DB:  PubMed          Journal:  Int J Vasc Med        ISSN: 2090-2824


× No keyword cloud information.
We read with interest the article by Al-Thani et al. [1] reporting a very low frequency (2.6%) of peripheral arterial disease (PAD) in people with acute coronary syndrome in a multicenter study conducted in six Middle Eastern countries. A recent multicenter study in Turkey showed 20% prevalence of PAD in people with established cardiovascular disease or who were at risk for atherosclerotic diseases [2]. Diabetes that was present in 70% of the participants in their study is actually a major cause of arterial stiffness or calcification, which frequently results in misclassification of diabetics in ankle brachial index (ABI) testing by causing paradoxically high values [3]. In this context, it would be utmost helpful if the authors could provide some data related to the prevalence of a high ABI (>1.4) in their study population, so that the readers could recognize whether a high ABI potentially influenced the frequency of a low ABI. Another point that should be noted is the method of assessment of PAD by ABI testing. In recent years, many societies published detailed consensus guidelines on the definition and management of PAD [4-6]. Collectively, the ABI cut-off value for the diagnosis of PAD is currently accepted as ≤0.9. Although ABI of <0.8 can be found in several surveys as the diagnostic threshold, adherence to guidelines and their updates would be a superior evidence-based approach. In such case, it could be speculated that the prevalence of PAD would be recorded some higher in the study by Al-Thani et al. A final concern is the need for a correct calculation of ABI. As explained clearly in the TASC II guidelines, [4] higher readings of dorsalis pedis or tibialis posterior arteries should be used as the numerator in the index formula. However, Al-Thani et al. used the average (i.e., mean of dorsalis pedis plus tibialis posterior records) systolic blood pressure readings in each ankle as the numerator in order to calculate the ABI ratio. Compared to guideline recommendations, this method obviously results in use of lower values for any ankle especially when one of the readings is lower than the other, causing an increase in the frequency of a low ABI. Opposite to our concern regarding the ABI cut-off in the previous section, such a calculation could further reduce the reported prevalence of PAD in this multicenter large scale survey. However, through a scientific view, this does not eliminate the potential limitations. We guess that the readers would appreciate if the authors could comment on these issues.
  6 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 2.  Use and utility of ankle brachial index in patients with diabetes.

Authors:  L Potier; C Abi Khalil; K Mohammedi; R Roussel
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-11-20       Impact factor: 7.069

3.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

4.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler
Journal:  J Am Coll Cardiol       Date:  2011-10-06       Impact factor: 24.094

5.  Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis--CAREFUL study: a national, multi-center, cross-sectional observational study.

Authors:  Ahmet K Bozkurt; Ilker Tasci; Omur Tabak; Mehmet Gumus; Yesim Kaplan
Journal:  BMC Cardiovasc Disord       Date:  2011-01-19       Impact factor: 2.298

6.  Peripheral arterial disease in patients presenting with acute coronary syndrome in six middle eastern countries.

Authors:  Hassan A Al-Thani; Ayman El-Menyar; Mohammad Zubaid; Wafa A Rashed; Mustafa Ridha; Wael Almahmeed; Kadhim Sulaiman; Ahmed Al-Motarreb; Haitham Amin; Jassim Al Suwaidi
Journal:  Int J Vasc Med       Date:  2011-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.